<html xmlns:v="urn:schemas-microsoft-com:vml"xmlns:o="urn:schemas-microsoft-com:office:office"xmlns:w="urn:schemas-microsoft-com:office:word"xmlns="http://www.w3.org/TR/REC-html40"><head><meta name=Title content="Sci-based INS"><meta name=Keywords content=""><meta http-equiv=Content-Type content="text/html; charset=macintosh"><meta name=ProgId content=Word.Document><meta name=Generator content="Microsoft Word 11"><meta name=Originator content="Microsoft Word 11"><link rel=File-List href="Sci_based%20INS_files/filelist.xml"><title>Sci-based INS</title><!--[if gte mso 9]><xml> <o:DocumentProperties>  <o:Author>LF Dell'Osso</o:Author>  <o:Template>DD_OMLAB_Papers</o:Template>  <o:LastAuthor>OMLAB VAMC</o:LastAuthor>  <o:Revision>2</o:Revision>  <o:LastPrinted>2011-05-04T17:59:00Z</o:LastPrinted>  <o:Created>2011-05-04T18:00:00Z</o:Created>  <o:LastSaved>2011-05-04T18:00:00Z</o:LastSaved>  <o:Pages>2</o:Pages>  <o:Words>4759</o:Words>  <o:Characters>27129</o:Characters>  <o:Lines>226</o:Lines>  <o:Paragraphs>54</o:Paragraphs>  <o:CharactersWithSpaces>33316</o:CharactersWithSpaces>  <o:Version>11.1280</o:Version> </o:DocumentProperties> <o:OfficeDocumentSettings>  <o:AllowPNG/>  <o:PixelsPerInch>300</o:PixelsPerInch> </o:OfficeDocumentSettings></xml><![endif]--><!--[if gte mso 9]><xml> <w:WordDocument>  <w:Zoom>150</w:Zoom>  <w:ActiveWritingStyle Lang="EN-US" VendorID="8" DLLVersion="513" NLCheck="0">1</w:ActiveWritingStyle>  <w:AttachedTemplate   HRef="EyeMac VI:Applications:MS Office 2004:Templates:My Templates:DD_OMLAB_Papers"></w:AttachedTemplate>  <w:DisplayHorizontalDrawingGridEvery>0</w:DisplayHorizontalDrawingGridEvery>  <w:DisplayVerticalDrawingGridEvery>0</w:DisplayVerticalDrawingGridEvery>  <w:UseMarginsForDrawingGridOrigin/>  <w:Compatibility>   <w:FootnoteLayoutLikeWW8/>   <w:ShapeLayoutLikeWW8/>   <w:AlignTablesRowByRow/>   <w:ForgetLastTabAlignment/>   <w:DoNotUseHTMLParagraphAutoSpacing/>   <w:LayoutRawTableWidth/>   <w:LayoutTableRowsApart/>   <w:UseWord97LineBreakingRules/>  </w:Compatibility>  <w:DocumentVariables>   <w:EN.InstantFormat>&lt;ENInstantFormat&gt;&lt;Enabled&gt;1&lt;/Enabled&gt;&lt;ScanUnformatted&gt;1&lt;/ScanUnformatted&gt;&lt;ScanChanges&gt;1&lt;/ScanChanges&gt;&lt;/ENInstantFormat&gt;</w:EN.InstantFormat>   <w:EN.Layout>&lt;ENLayout&gt;&lt;Style&gt;R_OMLAB&lt;/Style&gt;&lt;LeftDelim&gt;{&lt;/LeftDelim&gt;&lt;RightDelim&gt;}&lt;/RightDelim&gt;&lt;FontName&gt;Times&lt;/FontName&gt;&lt;FontSize&gt;12&lt;/FontSize&gt;&lt;ReflistTitle&gt;&lt;/ReflistTitle&gt;&lt;StartingRefnum&gt;1&lt;/StartingRefnum&gt;&lt;FirstLineIndent&gt;0&lt;/FirstLineIndent&gt;&lt;HangingIndent&gt;720&lt;/HangingIndent&gt;&lt;LineSpacing&gt;0&lt;/LineSpacing&gt;&lt;SpaceAfter&gt;0&lt;/SpaceAfter&gt;&lt;/ENLayout&gt;</w:EN.Layout>   <w:EN.Libraries>&lt;ENLibraries&gt;&lt;Libraries&gt;&lt;item&gt;scibased_INS.enl&lt;/item&gt;&lt;/Libraries&gt;&lt;/ENLibraries&gt;</w:EN.Libraries>   <w:EN_Lib_Name_List_Name>09OMref.enl</w:EN_Lib_Name_List_Name>  </w:DocumentVariables> </w:WordDocument></xml><![endif]--><style><!-- /* Font Definitions */@font-face	{font-family:"Times New Roman";	panose-1:0 2 2 6 3 5 4 5 2 3;	mso-font-charset:0;	mso-generic-font-family:auto;	mso-font-pitch:variable;	mso-font-signature:50331648 0 0 0 1 0;}@font-face	{font-family:Geneva;	panose-1:0 2 11 5 3 3 4 4 4 2;	mso-font-charset:0;	mso-generic-font-family:auto;	mso-font-pitch:variable;	mso-font-signature:50331648 0 0 0 1 0;}@font-face	{font-family:Times-Roman;	panose-1:0 0 0 0 0 0 0 0 0 0;	mso-font-alt:Times;	mso-font-charset:0;	mso-generic-font-family:roman;	mso-font-format:other;	mso-font-pitch:auto;	mso-font-signature:3 0 0 0 1 0;} /* Style Definitions */p.MsoNormal, li.MsoNormal, div.MsoNormal	{mso-style-parent:"";	margin:0in;	margin-bottom:.0001pt;	mso-pagination:widow-orphan;	font-size:12.0pt;	font-family:Times;}h1	{mso-style-next:Normal;	margin:0in;	margin-bottom:.0001pt;	mso-pagination:widow-orphan;	page-break-after:avoid;	mso-outline-level:1;	font-size:14.0pt;	font-family:Times;	mso-font-kerning:0pt;	font-weight:normal;	font-style:italic;}h2	{mso-style-next:Normal;	margin:0in;	margin-bottom:.0001pt;	mso-pagination:widow-orphan;	page-break-after:avoid;	mso-outline-level:2;	font-size:12.0pt;	font-family:Times;	font-weight:normal;	font-style:italic;}h3	{mso-style-next:Normal;	margin:0in;	margin-bottom:.0001pt;	mso-pagination:widow-orphan;	page-break-after:avoid;	mso-outline-level:3;	font-size:14.0pt;	font-family:Times;	font-style:italic;}h4	{mso-style-next:Normal;	margin:0in;	margin-bottom:.0001pt;	text-align:center;	mso-pagination:widow-orphan;	page-break-after:avoid;	mso-outline-level:4;	font-size:12.0pt;	font-family:Times;}h5	{mso-style-next:Normal;	margin-top:0in;	margin-right:0in;	margin-bottom:0in;	margin-left:-27.0pt;	margin-bottom:.0001pt;	text-align:justify;	line-height:150%;	mso-pagination:widow-orphan;	page-break-after:avoid;	mso-outline-level:5;	font-size:14.0pt;	font-family:Times;	font-style:italic;}h6	{mso-style-next:Normal;	margin-top:0in;	margin-right:0in;	margin-bottom:0in;	margin-left:-27.0pt;	margin-bottom:.0001pt;	text-align:justify;	line-height:150%;	mso-pagination:widow-orphan;	page-break-after:avoid;	mso-outline-level:6;	font-size:12.0pt;	font-family:Times;	font-style:italic;}p.MsoHeader, li.MsoHeader, div.MsoHeader	{margin:0in;	margin-bottom:.0001pt;	mso-pagination:widow-orphan;	tab-stops:center 3.0in right 6.0in;	font-size:12.0pt;	font-family:Times;}p.MsoFooter, li.MsoFooter, div.MsoFooter	{margin:0in;	margin-bottom:.0001pt;	mso-pagination:widow-orphan;	tab-stops:center 3.0in right 6.0in;	font-size:12.0pt;	font-family:Times;}p.MsoBodyText, li.MsoBodyText, div.MsoBodyText	{margin:0in;	margin-bottom:.0001pt;	text-align:center;	mso-pagination:widow-orphan;	font-size:22.0pt;	font-family:Times;}p.MsoBodyTextIndent, li.MsoBodyTextIndent, div.MsoBodyTextIndent	{margin-top:0in;	margin-right:0in;	margin-bottom:0in;	margin-left:-27.0pt;	margin-bottom:.0001pt;	line-height:150%;	mso-pagination:widow-orphan;	font-size:12.0pt;	font-family:Times;}p.MsoBodyText2, li.MsoBodyText2, div.MsoBodyText2	{margin:0in;	margin-bottom:.0001pt;	line-height:150%;	mso-pagination:widow-orphan;	font-size:10.0pt;	font-family:Times;}p.MsoBodyText3, li.MsoBodyText3, div.MsoBodyText3	{margin:0in;	margin-bottom:.0001pt;	text-align:justify;	mso-pagination:widow-orphan;	mso-outline-level:1;	font-size:12.0pt;	font-family:Times;}p.MsoBodyTextIndent2, li.MsoBodyTextIndent2, div.MsoBodyTextIndent2	{margin-top:0in;	margin-right:0in;	margin-bottom:0in;	margin-left:-27.0pt;	margin-bottom:.0001pt;	text-align:justify;	line-height:150%;	mso-pagination:widow-orphan;	font-size:12.0pt;	font-family:Times;}a:link, span.MsoHyperlink	{color:blue;	text-decoration:underline;	text-underline:single;}a:visited, span.MsoHyperlinkFollowed	{color:purple;	text-decoration:underline;	text-underline:single;}p.MsoDocumentMap, li.MsoDocumentMap, div.MsoDocumentMap	{margin:0in;	margin-bottom:.0001pt;	mso-pagination:widow-orphan;	background:navy;	font-size:12.0pt;	font-family:Geneva;}table.MsoNormalTable	{mso-style-parent:"";	font-size:10.0pt;	font-family:"Times New Roman";}@page Section1	{size:8.5in 11.0in;	margin:1.0in 1.0in 1.0in 1.0in;	mso-header-margin:.5in;	mso-footer-margin:.55in;	mso-page-numbers:1;	mso-title-page:yes;	mso-header:url(":Sci_based INS_files:header.htm") h1;	mso-footer:url(":Sci_based INS_files:header.htm") f1;	mso-first-header:url(":Sci_based INS_files:header.htm") fh1;	mso-first-footer:url(":Sci_based INS_files:header.htm") ff1;	mso-paper-source:0;}div.Section1	{page:Section1;} /* List Definitions */@list l0	{mso-list-id:1142234758;	mso-list-type:hybrid;	mso-list-template-ids:-1776623994 67698703 67698713 67698715 67698703 67698713 67698715 67698703 67698713 67698715;}@list l0:level1	{mso-level-tab-stop:.5in;	mso-level-number-position:left;	text-indent:-.25in;}@list l1	{mso-list-id:1226991875;	mso-list-type:hybrid;	mso-list-template-ids:1193431162 67698703 67698713 67698715 67698703 67698713 67698715 67698703 67698713 67698715;}@list l1:level1	{mso-level-tab-stop:.5in;	mso-level-number-position:left;	text-indent:-.25in;}@list l2	{mso-list-id:1593246770;	mso-list-type:hybrid;	mso-list-template-ids:707930280 67698703 67698713 67698715 67698703 67698713 67698715 67698703 67698713 67698715;}@list l2:level1	{mso-level-tab-stop:.5in;	mso-level-number-position:left;	text-indent:-.25in;}ol	{margin-bottom:0in;}ul	{margin-bottom:0in;}--></style><!--[if gte mso 9]><xml> <o:shapedefaults v:ext="edit" spidmax="2050"/></xml><![endif]--><!--[if gte mso 9]><xml> <o:shapelayout v:ext="edit">  <o:idmap v:ext="edit" data="1"/> </o:shapelayout></xml><![endif]--></head><body bgcolor=white lang=EN-US link=blue vlink=purple style='tab-interval:.5in'><div class=Section1><p class=MsoBodyText><a name="OLE_LINK3"><span style='font-size:16.0pt'><b>AppropriateOutcome Measures for Infantile Nystagmus Therapies:<o:p></o:p></b></span></a></p><p class=MsoBodyText><span style='mso-bookmark:OLE_LINK3'><spanstyle='font-size:16.0pt'><b>“Science-based” not “Evidence-based” Studies</b></span></span><b><o:p></o:p></b></p><p class=MsoNormal style='text-align:justify'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p><p class=MsoNormal align=center style='text-align:center;mso-outline-level:1'><span style='font-size:14.0pt'>Louis F. Dell’Osso, PhD<o:p></o:p></span></p><p class=MsoNormal style='text-align:justify'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p><p class=MsoNormal style='text-align:justify'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p><p class=MsoNormal style='mso-pagination:none;mso-layout-grid-align:none;text-autospace:none'><b>OMLAB Editorial #010410</b><span style='font-weight:normal'><o:p></o:p></span></p><p class=MsoNormal style='mso-pagination:none;mso-layout-grid-align:none;text-autospace:none'><b>Written:</b><span style='font-weight:normal'> 1/4/10; </span><b>Placedon Web Page:</b><span style='font-weight:normal'> 1/4/10; </span><b>LastModified:</b><span style='font-weight:normal'> 1/5/10<o:p></o:p></span></p><p class=MsoNormal style='mso-pagination:none;mso-layout-grid-align:none;text-autospace:none'><b>Downloaded from:</b><span style='font-weight:normal'>OMLAB.ORG<o:p></o:p></span></p><p class=MsoNormal style='mso-pagination:none;mso-layout-grid-align:none;text-autospace:none'><b><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></b></p><p class=MsoNormal style='mso-pagination:none;mso-layout-grid-align:none;text-autospace:none'><b>Send questions, comments, and suggestions to:</b><spanstyle='font-weight:normal'> lfd@case.edu<o:p></o:p></span></p><p class=MsoNormal style='text-align:justify'><span style='font-size:11.0pt'>&nbsp;<o:p></o:p></span></p><p class=MsoNormal style='text-align:justify'><span style='font-size:11.0pt'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoBodyTextIndent style='margin-left:0in;line-height:normal'><spanstyle='font-size:11.0pt'>The past forty years of research into infantilenystagmus syndrome (INS, aka “congenital nystagmus”) </span><!--[if supportFields]><spanstyle='font-size:11.0pt'><span style='mso-element:field-begin'></span><spanstyle="mso-spacerun: yes">&nbsp;</span>ADDIN EN.CITE&lt;EndNote&gt;&lt;Cite&gt;&lt;Author&gt;CEMAS_Working_Group&lt;/Author&gt;&lt;Year&gt;2001&lt;/Year&gt;&lt;RecNum&gt;1&lt;/RecNum&gt;&lt;record&gt;&lt;rec-number&gt;1&lt;/rec-number&gt;&lt;foreign-keys&gt;&lt;keyapp=&quot;EN&quot;db-id=&quot;e52rs22ptff5dqeetz3v5spffaaetzfpz2vf&quot;&gt;1&lt;/key&gt;&lt;/foreign-keys&gt;&lt;ref-typename=&quot;Report&quot;&gt;27&lt;/ref-type&gt;&lt;contributors&gt;&lt;authors&gt;&lt;author&gt;CEMAS_Working_Group&lt;/author&gt;&lt;/authors&gt;&lt;/contributors&gt;&lt;titles&gt;&lt;title&gt;ANational Eye Institute Sponsored Workshop and Publication on The Classificationof Eye Movement Abnormalities and Strabismus (CEMAS). In The National EyeInstitute Publications (www.nei.nih.gov/news/statements/cemas.pdf)&lt;/title&gt;&lt;/titles&gt;&lt;keywords&gt;&lt;keyword&gt;NYST:STRAB:&lt;/keyword&gt;&lt;/keywords&gt;&lt;dates&gt;&lt;year&gt;2001&lt;/year&gt;&lt;/dates&gt;&lt;pub-location&gt;Bethesda,MD&lt;/pub-location&gt;&lt;publisher&gt;National Institutes of Health, NationalEye Institute&lt;/publisher&gt;&lt;label&gt;5.89&lt;/label&gt;&lt;urls&gt;&lt;/urls&gt;&lt;/record&gt;&lt;/Cite&gt;&lt;/EndNote&gt;<spanstyle='mso-element:field-separator'></span></span><![endif]--><spanstyle='font-size:11.0pt'>(1)</span><!--[if supportFields]><spanstyle='font-size:11.0pt'><span style='mso-element:field-end'></span></span><![endif]--><spanstyle='font-size:11.0pt'> have resulted in basic changes in our understandingof its underlying mechanism, provided new and more powerful methods ofeye-movement-based analysis, laid to rest some simplistic ophthalmologicalmisconceptions, and resulted in a paradigm shift in our approach to extraocularmuscle (EOM) surgical and non-surgical nystagmus therapies. Unfortunately,incorporating these new approaches and analysis measures into studies oftherapeutic efficacy in INS has met with resistance and suggestions by fundingagencies to replace the best scientific outcome measures with less effective,inadequate measures (see below, interchange at a scientific meeting).<o:p></o:p></span></p><p class=MsoBodyTextIndent style='margin-left:0in;line-height:normal'><spanstyle='font-size:11.0pt'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoBodyTextIndent style='margin-left:0in;line-height:normal'><spanstyle='font-size:11.0pt'>This editorial will: 1) briefly summarize what we havelearned from predominantly classical studies of INS; 2) discuss theimplications for studies of potential therapies; 3) identify current problemsfacing scientists; and 4) suggest a solution. Although each of these topicscould easily be the subject of an individual editorial, because they areinterrelated, they have been combined herein.<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoNormal><a name="OLE_LINK6"></a><a name="OLE_LINK4"><spanstyle='mso-bookmark:OLE_LINK6'><span style='font-size:11.0pt'><b>Review of theScience</b></span></span></a><span style='mso-bookmark:OLE_LINK4'><spanstyle='mso-bookmark:OLE_LINK6'><span style='font-size:11.0pt'><o:p></o:p></span></span></span></p><span style='mso-bookmark:OLE_LINK4'></span><p class=MsoNormal><span style='mso-bookmark:OLE_LINK6'><span style='font-size:11.0pt'>Early in the ocular motor study of INS, it became obvious that INS wasthe <i>same</i></span></span><span style='mso-bookmark:OLE_LINK6'><spanstyle='font-size:11.0pt'> ocular motor disorder despite differences in theassociated visual sensory conditions of the patient population. All patientsshared the same pathognomonic waveforms </span></span><!--[if supportFields]><spanstyle='mso-bookmark:OLE_LINK6'></span><span style='mso-element:field-begin'></span><spanstyle='mso-bookmark:OLE_LINK6'><span style='font-size:11.0pt'><spanstyle="mso-spacerun: yes">&nbsp;</span>ADDIN EN.CITE&lt;EndNote&gt;&lt;Cite&gt;&lt;Author&gt;Dell&amp;apos;Osso&lt;/Author&gt;&lt;Year&gt;1975&lt;/Year&gt;&lt;RecNum&gt;26&lt;/RecNum&gt;&lt;record&gt;&lt;rec-number&gt;26&lt;/rec-number&gt;&lt;foreign-keys&gt;&lt;keyapp=&quot;EN&quot; db-id=&quot;e52rs22ptff5dqeetz3v5spffaaetzfpz2vf&quot;&gt;26&lt;/key&gt;&lt;/foreign-keys&gt;&lt;ref-typename=&quot;JournalArticle&quot;&gt;17&lt;/ref-type&gt;&lt;contributors&gt;&lt;authors&gt;&lt;author&gt;Dell&amp;apos;Osso,L. F.&lt;/author&gt;&lt;author&gt;Daroff, R.B.&lt;/author&gt;&lt;/authors&gt;&lt;/contributors&gt;&lt;titles&gt;&lt;title&gt;Congenitalnystagmus waveforms and foveation strategy&lt;/title&gt;&lt;secondary-title&gt;DocOphthalmol&lt;/secondary-title&gt;&lt;/titles&gt;&lt;pages&gt;155-182&lt;/pages&gt;&lt;volume&gt;39&lt;/volume&gt;&lt;keywords&gt;&lt;keyword&gt;Cn:fov: wfms: vacty: cmn:&lt;/keyword&gt;&lt;/keywords&gt;&lt;dates&gt;&lt;year&gt;1975&lt;/year&gt;&lt;/dates&gt;&lt;label&gt;1.18&lt;/label&gt;&lt;urls&gt;&lt;/urls&gt;&lt;/record&gt;&lt;/Cite&gt;&lt;/EndNote&gt;<spanstyle='mso-element:field-separator'></span></span></span><![endif]--><spanstyle='mso-bookmark:OLE_LINK6'><span style='font-size:11.0pt'>(2)</span></span><!--[if supportFields]><spanstyle='mso-bookmark:OLE_LINK6'></span><span style='mso-element:field-end'></span><![endif]--><spanstyle='mso-bookmark:OLE_LINK6'><span style='font-size:11.0pt'> andcharacteristic changes with gaze angle, vergence angle, fixating eye, etc. thatwere uncorrelated to the presence or absence of any sensory deficits. Thecommonality of INS waveforms suggested the same underlying ocular motormechanism(s) and the same therapies to improve motor function in all INSpatients regardless of the presence or absence of sensory deficits. Thisimportant point is often overlooked in studies that artificially separatepatient populations based on either their associated sensory deficits or, morerecently, some genetic marker whose relationship to INS is as yet unknown.<o:p></o:p></span></span></p><p class=MsoNormal><span style='mso-bookmark:OLE_LINK6'><span style='font-size:11.0pt'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></span></p><p class=MsoNormal><span style='mso-bookmark:OLE_LINK6'><span style='font-size:11.0pt'>In the first ocular motor study of the effects of EOM surgery, we notedthat the surgery produced beneficial, unanticipated, and unexplained effects </span></span><!--[if supportFields]><spanstyle='mso-bookmark:OLE_LINK6'></span><span style='mso-element:field-begin'></span><spanstyle='mso-bookmark:OLE_LINK6'><span style='font-size:11.0pt'><spanstyle="mso-spacerun: yes">&nbsp;</span>ADDIN EN.CITE&lt;EndNote&gt;&lt;Cite&gt;&lt;Author&gt;Dell&amp;apos;Osso&lt;/Author&gt;&lt;Year&gt;1979&lt;/Year&gt;&lt;RecNum&gt;10&lt;/RecNum&gt;&lt;record&gt;&lt;rec-number&gt;10&lt;/rec-number&gt;&lt;foreign-keys&gt;&lt;keyapp=&quot;EN&quot; db-id=&quot;e52rs22ptff5dqeetz3v5spffaaetzfpz2vf&quot;&gt;10&lt;/key&gt;&lt;/foreign-keys&gt;&lt;ref-typename=&quot;Journal Article&quot;&gt;17&lt;/ref-type&gt;&lt;contributors&gt;&lt;authors&gt;&lt;author&gt;Dell&amp;apos;Osso,L. F.&lt;/author&gt;&lt;author&gt;Flynn, J.T.&lt;/author&gt;&lt;/authors&gt;&lt;/contributors&gt;&lt;titles&gt;&lt;title&gt;Congenitalnystagmus surgery: a quantitative evaluation of theeffects&lt;/title&gt;&lt;secondary-title&gt;Arch Ophthalmol&lt;/secondary-title&gt;&lt;/titles&gt;&lt;pages&gt;462-469&lt;/pages&gt;&lt;volume&gt;97&lt;/volume&gt;&lt;keywords&gt;&lt;keyword&gt;CN:VACTY: CMN:SURG:&lt;/keyword&gt;&lt;/keywords&gt;&lt;dates&gt;&lt;year&gt;1979&lt;/year&gt;&lt;/dates&gt;&lt;label&gt;1.28&lt;/label&gt;&lt;urls&gt;&lt;/urls&gt;&lt;/record&gt;&lt;/Cite&gt;&lt;/EndNote&gt;<spanstyle='mso-element:field-separator'></span></span></span><![endif]--><spanstyle='mso-bookmark:OLE_LINK6'><span style='font-size:11.0pt'>(3)</span></span><!--[if supportFields]><spanstyle='mso-bookmark:OLE_LINK6'></span><span style='mso-element:field-end'></span><![endif]--><spanstyle='mso-bookmark:OLE_LINK6'><span style='font-size:11.0pt'>. In addition toshifting an eccentric INS null region to primary position, the four-muscleKestenbaum procedure (i.e., bilateral horizontal rectus recessions andresections) also improved the waveforms and, more importantly, did so over abroader range of gaze angles. This is best expressed in terms of the eXpandedNystagmus Acuity Function (NAFX), which is linearly proportional to thebest-corrected visual acuity possible with that waveform (i.e., presuming noafferent deficits) </span></span><!--[if supportFields]><span style='mso-bookmark:OLE_LINK6'></span><span style='mso-element:field-begin'></span><spanstyle='mso-bookmark:OLE_LINK6'><span style='font-size:11.0pt'><spanstyle="mso-spacerun: yes">&nbsp;</span>ADDIN EN.CITE&lt;EndNote&gt;&lt;Cite&gt;&lt;Author&gt;Dell&amp;apos;Osso&lt;/Author&gt;&lt;Year&gt;2002&lt;/Year&gt;&lt;RecNum&gt;16&lt;/RecNum&gt;&lt;record&gt;&lt;rec-number&gt;16&lt;/rec-number&gt;&lt;foreign-keys&gt;&lt;keyapp=&quot;EN&quot;db-id=&quot;e52rs22ptff5dqeetz3v5spffaaetzfpz2vf&quot;&gt;16&lt;/key&gt;&lt;/foreign-keys&gt;&lt;ref-typename=&quot;JournalArticle&quot;&gt;17&lt;/ref-type&gt;&lt;contributors&gt;&lt;authors&gt;&lt;author&gt;Dell&amp;apos;Osso,L. F.&lt;/author&gt;&lt;author&gt;Jacobs, J.B.&lt;/author&gt;&lt;/authors&gt;&lt;/contributors&gt;&lt;titles&gt;&lt;title&gt;Anexpanded nystagmus acuity function: intra- and intersubject prediction ofbest-corrected visual acuity&lt;/title&gt;&lt;secondary-title&gt;DocOphthalmol&lt;/secondary-title&gt;&lt;/titles&gt;&lt;pages&gt;249-276&lt;/pages&gt;&lt;volume&gt;104&lt;/volume&gt;&lt;keywords&gt;&lt;keyword&gt;NAFX:CN:VACTY:&lt;/keyword&gt;&lt;/keywords&gt;&lt;dates&gt;&lt;year&gt;2002&lt;/year&gt;&lt;/dates&gt;&lt;label&gt;5.63&lt;/label&gt;&lt;urls&gt;&lt;/urls&gt;&lt;/record&gt;&lt;/Cite&gt;&lt;/EndNote&gt;<spanstyle='mso-element:field-separator'></span></span></span><![endif]--><spanstyle='mso-bookmark:OLE_LINK6'><span style='font-size:11.0pt'>(4)</span></span><!--[if supportFields]><spanstyle='mso-bookmark:OLE_LINK6'></span><span style='mso-element:field-end'></span><![endif]--><spanstyle='mso-bookmark:OLE_LINK6'><span style='font-size:11.0pt'>. Four-muscle EOMsurgery improves the peak NAFX and broadens the range of gaze angles with highNAFX values (i.e., the longest foveation domain, or LFD) </span></span><!--[if supportFields]><spanstyle='mso-bookmark:OLE_LINK6'></span><span style='mso-element:field-begin'></span><spanstyle='mso-bookmark:OLE_LINK6'><span style='font-size:11.0pt'><spanstyle="mso-spacerun: yes">&nbsp;</span>ADDIN EN.CITE&lt;EndNote&gt;&lt;Cite&gt;&lt;Author&gt;Wang&lt;/Author&gt;&lt;Year&gt;2006&lt;/Year&gt;&lt;RecNum&gt;2&lt;/RecNum&gt;&lt;record&gt;&lt;rec-number&gt;2&lt;/rec-number&gt;&lt;foreign-keys&gt;&lt;keyapp=&quot;EN&quot; db-id=&quot;e52rs22ptff5dqeetz3v5spffaaetzfpz2vf&quot;&gt;2&lt;/key&gt;&lt;/foreign-keys&gt;&lt;ref-typename=&quot;JournalArticle&quot;&gt;17&lt;/ref-type&gt;&lt;contributors&gt;&lt;authors&gt;&lt;author&gt;Wang,Z.&lt;/author&gt;&lt;author&gt;Dell&amp;apos;Osso, L. F.&lt;/author&gt;&lt;author&gt;Jacobs,J. B.&lt;/author&gt;&lt;author&gt;Burnstine, R. A.&lt;/author&gt;&lt;author&gt;Tomsak,R.L.&lt;/author&gt;&lt;/authors&gt;&lt;/contributors&gt;&lt;titles&gt;&lt;title&gt;Effectsof tenotomy on patients with infantile nystagmus syndrome: foveationimprovement over a broadened visualfield&lt;/title&gt;&lt;secondary-title&gt;JAAPOS&lt;/secondary-title&gt;&lt;/titles&gt;&lt;pages&gt;552-560&lt;/pages&gt;&lt;volume&gt;10&lt;/volume&gt;&lt;keywords&gt;&lt;keyword&gt;CN:SURG: TENOT: NAFX:LFD:&lt;/keyword&gt;&lt;/keywords&gt;&lt;dates&gt;&lt;year&gt;2006&lt;/year&gt;&lt;/dates&gt;&lt;label&gt;5.243&lt;/label&gt;&lt;urls&gt;&lt;/urls&gt;&lt;/record&gt;&lt;/Cite&gt;&lt;/EndNote&gt;<spanstyle='mso-element:field-separator'></span></span></span><![endif]--><spanstyle='mso-bookmark:OLE_LINK6'><span style='font-size:11.0pt'>(5)</span></span><!--[if supportFields]><spanstyle='mso-bookmark:OLE_LINK6'></span><span style='mso-element:field-end'></span><![endif]--><spanstyle='mso-bookmark:OLE_LINK6'><span style='font-size:11.0pt'>. The 1979Kestenbaum study </span></span><!--[if supportFields]><span style='mso-bookmark:OLE_LINK6'></span><span style='mso-element:field-begin'></span><spanstyle='mso-bookmark:OLE_LINK6'><span style='font-size:11.0pt'><spanstyle="mso-spacerun: yes">&nbsp;</span>ADDIN EN.CITE&lt;EndNote&gt;&lt;Cite&gt;&lt;Author&gt;Dell&amp;apos;Osso&lt;/Author&gt;&lt;Year&gt;1979&lt;/Year&gt;&lt;RecNum&gt;10&lt;/RecNum&gt;&lt;record&gt;&lt;rec-number&gt;10&lt;/rec-number&gt;&lt;foreign-keys&gt;&lt;keyapp=&quot;EN&quot; db-id=&quot;e52rs22ptff5dqeetz3v5spffaaetzfpz2vf&quot;&gt;10&lt;/key&gt;&lt;/foreign-keys&gt;&lt;ref-typename=&quot;JournalArticle&quot;&gt;17&lt;/ref-type&gt;&lt;contributors&gt;&lt;authors&gt;&lt;author&gt;Dell&amp;apos;Osso,L. F.&lt;/author&gt;&lt;author&gt;Flynn, J.T.&lt;/author&gt;&lt;/authors&gt;&lt;/contributors&gt;&lt;titles&gt;&lt;title&gt;Congenitalnystagmus surgery: a quantitative evaluation of the effects&lt;/title&gt;&lt;secondary-title&gt;ArchOphthalmol&lt;/secondary-title&gt;&lt;/titles&gt;&lt;pages&gt;462-469&lt;/pages&gt;&lt;volume&gt;97&lt;/volume&gt;&lt;keywords&gt;&lt;keyword&gt;CN:VACTY: CMN:SURG:&lt;/keyword&gt;&lt;/keywords&gt;&lt;dates&gt;&lt;year&gt;1979&lt;/year&gt;&lt;/dates&gt;&lt;label&gt;1.28&lt;/label&gt;&lt;urls&gt;&lt;/urls&gt;&lt;/record&gt;&lt;/Cite&gt;&lt;/EndNote&gt;<spanstyle='mso-element:field-separator'></span></span></span><![endif]--><spanstyle='mso-bookmark:OLE_LINK6'><span style='font-size:11.0pt'>(3)</span></span><!--[if supportFields]><spanstyle='mso-bookmark:OLE_LINK6'></span><span style='mso-element:field-end'></span><![endif]--><spanstyle='mso-bookmark:OLE_LINK6'><span style='font-size:11.0pt'> produced thehypothesis that these therapeutic improvements would result from simplytenotomizing, and reattaching at their original insertions, the four EOM in theplane of the INS&#8212;the tenotomy and reattachment (T&amp;R) procedure </span></span><!--[if supportFields]><spanstyle='mso-bookmark:OLE_LINK6'></span><span style='mso-element:field-begin'></span><spanstyle='mso-bookmark:OLE_LINK6'><span style='font-size:11.0pt'><spanstyle="mso-spacerun: yes">&nbsp;</span>ADDIN EN.CITE&lt;EndNote&gt;&lt;Cite&gt;&lt;Author&gt;Dell&amp;apos;Osso&lt;/Author&gt;&lt;Year&gt;1998&lt;/Year&gt;&lt;RecNum&gt;12&lt;/RecNum&gt;&lt;record&gt;&lt;rec-number&gt;12&lt;/rec-number&gt;&lt;foreign-keys&gt;&lt;keyapp=&quot;EN&quot;db-id=&quot;e52rs22ptff5dqeetz3v5spffaaetzfpz2vf&quot;&gt;12&lt;/key&gt;&lt;/foreign-keys&gt;&lt;ref-typename=&quot;Journal Article&quot;&gt;17&lt;/ref-type&gt;&lt;contributors&gt;&lt;authors&gt;&lt;author&gt;Dell&amp;apos;Osso,L. F.&lt;/author&gt;&lt;/authors&gt;&lt;/contributors&gt;&lt;titles&gt;&lt;title&gt;Extraocularmuscle tenotomy, dissection, and suture: A hypothetical therapy for congenitalnystagmus&lt;/title&gt;&lt;secondary-title&gt;J Pediatr OphthalmolStrab&lt;/secondary-title&gt;&lt;/titles&gt;&lt;pages&gt;232-233&lt;/pages&gt;&lt;volume&gt;35&lt;/volume&gt;&lt;keywords&gt;&lt;keyword&gt;CN:SURG:TENOT:&lt;/keyword&gt;&lt;/keywords&gt;&lt;dates&gt;&lt;year&gt;1998&lt;/year&gt;&lt;/dates&gt;&lt;label&gt;4.497&lt;/label&gt;&lt;urls&gt;&lt;/urls&gt;&lt;/record&gt;&lt;/Cite&gt;&lt;/EndNote&gt;<spanstyle='mso-element:field-separator'></span></span></span><![endif]--><spanstyle='mso-bookmark:OLE_LINK6'><span style='font-size:11.0pt'>(6)</span></span><!--[if supportFields]><spanstyle='mso-bookmark:OLE_LINK6'></span><span style='mso-element:field-end'></span><![endif]--><spanstyle='mso-bookmark:OLE_LINK6'><span style='font-size:11.0pt'>.<o:p></o:p></span></span></p><p class=MsoNormal><span style='mso-bookmark:OLE_LINK6'><span style='font-size:11.0pt'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></span></p><p class=MsoNormal><span style='mso-bookmark:OLE_LINK6'><span style='font-size:11.0pt'>Because the NAFX was specifically designed to account for only themotor factors that reduce the quality of target foveation, it uniquelyseparates out the motor component of measured visual acuity from any sensorycomponent that may be present. This important quality enables, for the firsttime, pre-therapy estimation of post-therapy <i>measured</i></span></span><spanstyle='mso-bookmark:OLE_LINK6'><span style='font-size:11.0pt'> peak visualacuity and the range of gaze angles with higher acuity. It is important, andnot universally appreciated, that the measured improvements in INS are producedequally in patients with and without associated sensory deficits. This newmethodology </span></span><!--[if supportFields]><span style='mso-bookmark:OLE_LINK6'></span><span style='mso-element:field-begin'></span><spanstyle='mso-bookmark:OLE_LINK6'><span style='font-size:11.0pt'><spanstyle="mso-spacerun: yes">&nbsp;</span>ADDIN EN.CITE &lt;EndNote&gt;&lt;Cite&gt;&lt;Author&gt;Wang&lt;/Author&gt;&lt;Year&gt;2007&lt;/Year&gt;&lt;RecNum&gt;6&lt;/RecNum&gt;&lt;record&gt;&lt;rec-number&gt;6&lt;/rec-number&gt;&lt;foreign-keys&gt;&lt;keyapp=&quot;EN&quot; db-id=&quot;e52rs22ptff5dqeetz3v5spffaaetzfpz2vf&quot;&gt;6&lt;/key&gt;&lt;/foreign-keys&gt;&lt;ref-typename=&quot;JournalArticle&quot;&gt;17&lt;/ref-type&gt;&lt;contributors&gt;&lt;authors&gt;&lt;author&gt;Wang,Z. I.&lt;/author&gt;&lt;author&gt;Dell&amp;apos;Osso, L.F.&lt;/author&gt;&lt;/authors&gt;&lt;/contributors&gt;&lt;titles&gt;&lt;title&gt;Areview of the tenotomy nystagmus surgery: origin, mechanism, and generalefficacy&lt;/title&gt;&lt;secondary-title&gt;Neuro-Ophthalmol&lt;/secondary-title&gt;&lt;/titles&gt;&lt;pages&gt;157-165&lt;/pages&gt;&lt;volume&gt;31&lt;/volume&gt;&lt;keywords&gt;&lt;keyword&gt;CN:SURG: NAFX: AN: LFD: DBN:VACTY:&lt;/keyword&gt;&lt;/keywords&gt;&lt;dates&gt;&lt;year&gt;2007&lt;/year&gt;&lt;/dates&gt;&lt;label&gt;5.260&lt;/label&gt;&lt;urls&gt;&lt;/urls&gt;&lt;/record&gt;&lt;/Cite&gt;&lt;Cite&gt;&lt;Author&gt;Dell&amp;apos;Osso&lt;/Author&gt;&lt;Year&gt;2008&lt;/Year&gt;&lt;RecNum&gt;20&lt;/RecNum&gt;&lt;record&gt;&lt;rec-number&gt;20&lt;/rec-number&gt;&lt;foreign-keys&gt;&lt;keyapp=&quot;EN&quot;db-id=&quot;e52rs22ptff5dqeetz3v5spffaaetzfpz2vf&quot;&gt;20&lt;/key&gt;&lt;/foreign-keys&gt;&lt;ref-typename=&quot;BookSection&quot;&gt;5&lt;/ref-type&gt;&lt;contributors&gt;&lt;authors&gt;&lt;author&gt;Dell&amp;apos;Osso,L. F.&lt;/author&gt;&lt;/authors&gt;&lt;secondary-authors&gt;&lt;author&gt;Leigh,R. J.&lt;/author&gt;&lt;author&gt;Devereaux, M.W.&lt;/author&gt;&lt;/secondary-authors&gt;&lt;/contributors&gt;&lt;titles&gt;&lt;title&gt;Newtreatments for infantile and other forms of nystagmus&lt;/title&gt;&lt;secondary-title&gt;Advancesin Understanding Mechanisms and Treatment of Congenital Forms ofNystagmus&lt;/secondary-title&gt;&lt;/titles&gt;&lt;pages&gt;87-98&lt;/pages&gt;&lt;keywords&gt;&lt;keyword&gt;CN:SURG: NAFX: AN: LFD: DBN:VACTY:&lt;/keyword&gt;&lt;/keywords&gt;&lt;dates&gt;&lt;year&gt;2008&lt;/year&gt;&lt;/dates&gt;&lt;pub-location&gt;NewYork&lt;/pub-location&gt;&lt;publisher&gt;Oxford UniversityPress&lt;/publisher&gt;&lt;label&gt;5.305&lt;/label&gt;&lt;urls&gt;&lt;/urls&gt;&lt;/record&gt;&lt;/Cite&gt;&lt;/EndNote&gt;<spanstyle='mso-element:field-separator'></span></span></span><![endif]--><spanstyle='mso-bookmark:OLE_LINK6'><span style='font-size:11.0pt'>(7,8)</span></span><!--[if supportFields]><spanstyle='mso-bookmark:OLE_LINK6'></span><span style='mso-element:field-end'></span><![endif]--><spanstyle='mso-bookmark:OLE_LINK6'><span style='font-size:11.0pt'> should have animportant role in establishing more scientifically based, and ethically sound,inclusion criteria for future studies of therapeutic efficacy (see below, TheSolution).<o:p></o:p></span></span></p><p class=MsoNormal><span style='mso-bookmark:OLE_LINK6'><span style='font-size:11.0pt'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></span></p><p class=MsoNormal><span style='mso-bookmark:OLE_LINK6'><span style='font-size:11.0pt'>The T&amp;R surgical procedure is a peripheral therapy that, inaddition to INS, also improves the waveforms of acquired pendular nystagmus (inmultiple sclerosis) and downbeat nystagmus, thereby reducing oscillopsia </span></span><!--[if supportFields]><spanstyle='mso-bookmark:OLE_LINK6'></span><span style='mso-element:field-begin'></span><spanstyle='mso-bookmark:OLE_LINK6'><span style='font-size:11.0pt'><spanstyle="mso-spacerun: yes">&nbsp;</span>ADDIN EN.CITE &lt;EndNote&gt;&lt;Cite&gt;&lt;Author&gt;Tomsak&lt;/Author&gt;&lt;Year&gt;2005&lt;/Year&gt;&lt;RecNum&gt;27&lt;/RecNum&gt;&lt;record&gt;&lt;rec-number&gt;27&lt;/rec-number&gt;&lt;foreign-keys&gt;&lt;keyapp=&quot;EN&quot; db-id=&quot;e52rs22ptff5dqeetz3v5spffaaetzfpz2vf&quot;&gt;27&lt;/key&gt;&lt;/foreign-keys&gt;&lt;ref-typename=&quot;Journal Article&quot;&gt;17&lt;/ref-type&gt;&lt;contributors&gt;&lt;authors&gt;&lt;author&gt;Tomsak,R. L.&lt;/author&gt;&lt;author&gt;Dell&amp;apos;Osso, L.F.&lt;/author&gt;&lt;author&gt;Rucker, J. C.&lt;/author&gt;&lt;author&gt;Leigh,R. J.&lt;/author&gt;&lt;author&gt;Bienfang, D. C.&lt;/author&gt;&lt;author&gt;Jacobs,J.B.&lt;/author&gt;&lt;/authors&gt;&lt;/contributors&gt;&lt;titles&gt;&lt;title&gt;Treatmentof acquired pendular nystagmus from multiple sclerosis with eye muscle surgeryfollowed by oralmemantine&lt;/title&gt;&lt;secondary-title&gt;DJO&lt;/secondary-title&gt;&lt;/titles&gt;&lt;pages&gt;1-11&lt;/pages&gt;&lt;volume&gt;11&lt;/volume&gt;&lt;number&gt;4&lt;/number&gt;&lt;keywords&gt;&lt;keyword&gt;Tenotomy:NAFX: APN: MS:drug:&lt;/keyword&gt;&lt;/keywords&gt;&lt;dates&gt;&lt;year&gt;2005&lt;/year&gt;&lt;/dates&gt;&lt;label&gt;5.224&lt;/label&gt;&lt;urls&gt;&lt;/urls&gt;&lt;/record&gt;&lt;/Cite&gt;&lt;Cite&gt;&lt;Author&gt;Wang&lt;/Author&gt;&lt;Year&gt;2007&lt;/Year&gt;&lt;RecNum&gt;5&lt;/RecNum&gt;&lt;record&gt;&lt;rec-number&gt;5&lt;/rec-number&gt;&lt;foreign-keys&gt;&lt;keyapp=&quot;EN&quot; db-id=&quot;e52rs22ptff5dqeetz3v5spffaaetzfpz2vf&quot;&gt;5&lt;/key&gt;&lt;/foreign-keys&gt;&lt;ref-typename=&quot;JournalArticle&quot;&gt;17&lt;/ref-type&gt;&lt;contributors&gt;&lt;authors&gt;&lt;author&gt;Wang,Z. I.&lt;/author&gt;&lt;author&gt;Dell&amp;apos;Osso, L. F.&lt;/author&gt;&lt;author&gt;Tomsak,R. L.&lt;/author&gt;&lt;author&gt;Jacobs, J.B.&lt;/author&gt;&lt;/authors&gt;&lt;/contributors&gt;&lt;titles&gt;&lt;title&gt;Combiningrecessions (nystagmus and strabismus) with tenotomy improved visual functionand decreased oscillopsia and diplopia in acquired downbeat nystagmus and inhorizontal infantile nystagmus syndrome&lt;/title&gt;&lt;secondary-title&gt;J AAPOS&lt;/secondary-title&gt;&lt;/titles&gt;&lt;pages&gt;135-141&lt;/pages&gt;&lt;volume&gt;11&lt;/volume&gt;&lt;keywords&gt;&lt;keyword&gt;CN:SURG: TENOT: STRAB: OSOP:DBN:&lt;/keyword&gt;&lt;/keywords&gt;&lt;dates&gt;&lt;year&gt;2007&lt;/year&gt;&lt;/dates&gt;&lt;label&gt;5.250&lt;/label&gt;&lt;urls&gt;&lt;/urls&gt;&lt;/record&gt;&lt;/Cite&gt;&lt;/EndNote&gt;<spanstyle='mso-element:field-separator'></span></span></span><![endif]--><spanstyle='mso-bookmark:OLE_LINK6'><span style='font-size:11.0pt'>(9,10)</span></span><!--[if supportFields]><spanstyle='mso-bookmark:OLE_LINK6'></span><span style='mso-element:field-end'></span><![endif]--><spanstyle='mso-bookmark:OLE_LINK6'><span style='font-size:11.0pt'>. The procedurereduces small-signal gain without altering saccadic gain or inducingundesirable plasticity changes </span></span><!--[if supportFields]><spanstyle='mso-bookmark:OLE_LINK6'></span><span style='mso-element:field-begin'></span><spanstyle='mso-bookmark:OLE_LINK6'><span style='font-size:11.0pt'><spanstyle="mso-spacerun: yes">&nbsp;</span>ADDIN EN.CITE&lt;EndNote&gt;&lt;Cite&gt;&lt;Author&gt;Wang&lt;/Author&gt;&lt;Year&gt;2006&lt;/Year&gt;&lt;RecNum&gt;3&lt;/RecNum&gt;&lt;record&gt;&lt;rec-number&gt;3&lt;/rec-number&gt;&lt;foreign-keys&gt;&lt;keyapp=&quot;EN&quot; db-id=&quot;e52rs22ptff5dqeetz3v5spffaaetzfpz2vf&quot;&gt;3&lt;/key&gt;&lt;/foreign-keys&gt;&lt;ref-typename=&quot;JournalArticle&quot;&gt;17&lt;/ref-type&gt;&lt;contributors&gt;&lt;authors&gt;&lt;author&gt;Wang,Z.&lt;/author&gt;&lt;author&gt;Dell&amp;apos;Osso, L.F.&lt;/author&gt;&lt;author&gt;Zhang, Z.&lt;/author&gt;&lt;author&gt;Leigh, R.J.&lt;/author&gt;&lt;author&gt;Jacobs, J.B.&lt;/author&gt;&lt;/authors&gt;&lt;/contributors&gt;&lt;auth-address&gt;Daroff-Dell&amp;apos;OssoOcular Motility Laboratory, Louis Stokes Cleveland Department of VeteransAffairs Medical Center, Cleveland, OH, USA; Department of BiomedicalEngineering, Case Western Reserve University and University Hospitals ofCleveland, Cleveland, OH,USA.&lt;/auth-address&gt;&lt;titles&gt;&lt;title&gt;Tenotomy does not affectsaccadic velocities: Support for the &amp;quot;small-signal&amp;quot; gainhypothesis&lt;/title&gt;&lt;secondary-title&gt;Vision Res&lt;/secondary-title&gt;&lt;/titles&gt;&lt;pages&gt;2259-2267&lt;/pages&gt;&lt;volume&gt;46&lt;/volume&gt;&lt;keywords&gt;&lt;keyword&gt;Tenotomy:sacc: vel: NAFX: SURG: PLNT:NYST:&lt;/keyword&gt;&lt;/keywords&gt;&lt;dates&gt;&lt;year&gt;2006&lt;/year&gt;&lt;/dates&gt;&lt;accession-num&gt;16497352&lt;/accession-num&gt;&lt;label&gt;5.223&lt;/label&gt;&lt;urls&gt;&lt;related-urls&gt;&lt;url&gt;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Citation&amp;amp;list_uids=16497352&lt;/url&gt;&lt;/related-urls&gt;&lt;/urls&gt;&lt;/record&gt;&lt;/Cite&gt;&lt;/EndNote&gt;<spanstyle='mso-element:field-separator'></span></span></span><![endif]--><spanstyle='mso-bookmark:OLE_LINK6'><span style='font-size:11.0pt'>(11)</span></span><!--[if supportFields]><spanstyle='mso-bookmark:OLE_LINK6'></span><span style='mso-element:field-end'></span><![endif]--><spanstyle='mso-bookmark:OLE_LINK6'><span style='font-size:11.0pt'>. Similarimprovements result from either the use of base-out prisms (to induce convergence)or soft contact lenses </span></span><!--[if supportFields]><spanstyle='mso-bookmark:OLE_LINK6'></span><span style='mso-element:field-begin'></span><spanstyle='mso-bookmark:OLE_LINK6'><span style='font-size:11.0pt'><spanstyle="mso-spacerun: yes">&nbsp;</span>ADDIN EN.CITE&lt;EndNote&gt;&lt;Cite&gt;&lt;Author&gt;Taibbi&lt;/Author&gt;&lt;Year&gt;2008&lt;/Year&gt;&lt;RecNum&gt;28&lt;/RecNum&gt;&lt;record&gt;&lt;rec-number&gt;28&lt;/rec-number&gt;&lt;foreign-keys&gt;&lt;keyapp=&quot;EN&quot;db-id=&quot;e52rs22ptff5dqeetz3v5spffaaetzfpz2vf&quot;&gt;28&lt;/key&gt;&lt;/foreign-keys&gt;&lt;ref-typename=&quot;JournalArticle&quot;&gt;17&lt;/ref-type&gt;&lt;contributors&gt;&lt;authors&gt;&lt;author&gt;Taibbi,G.&lt;/author&gt;&lt;author&gt;Wang, Z.I.&lt;/author&gt;&lt;author&gt;Dell&amp;apos;Osso, L.F.&lt;/author&gt;&lt;/authors&gt;&lt;/contributors&gt;&lt;titles&gt;&lt;title&gt;Infantilenystagmus syndrome: broadening the high-foveation-quality field with contactlenses&lt;/title&gt;&lt;secondary-title&gt;ClinOphthalmol&lt;/secondary-title&gt;&lt;/titles&gt;&lt;pages&gt;585-590&lt;/pages&gt;&lt;volume&gt;2&lt;/volume&gt;&lt;keywords&gt;&lt;keyword&gt;CN:NYST: WFM: VACTY:&lt;/keyword&gt;&lt;/keywords&gt;&lt;dates&gt;&lt;year&gt;2008&lt;/year&gt;&lt;/dates&gt;&lt;label&gt;5.329&lt;/label&gt;&lt;urls&gt;&lt;/urls&gt;&lt;/record&gt;&lt;/Cite&gt;&lt;/EndNote&gt;<spanstyle='mso-element:field-separator'></span></span></span><![endif]--><spanstyle='mso-bookmark:OLE_LINK6'><span style='font-size:11.0pt'>(12)</span></span><!--[if supportFields]><spanstyle='mso-bookmark:OLE_LINK6'></span><span style='mso-element:field-end'></span><![endif]--><spanstyle='mso-bookmark:OLE_LINK6'><span style='font-size:11.0pt'>. In addition tothe two static therapeutic improvements in visual function (higher peak NAFXand broader LFD), four-muscle EOM surgery improves the long target acquisitiontime (Lt) in INS </span></span><!--[if supportFields]><span style='mso-bookmark:OLE_LINK6'></span><span style='mso-element:field-begin'></span><spanstyle='mso-bookmark:OLE_LINK6'><span style='font-size:11.0pt'><spanstyle="mso-spacerun: yes">&nbsp;</span>ADDIN EN.CITE </span></span><spanstyle='mso-element:field-begin'></span><span style='mso-bookmark:OLE_LINK6'><spanstyle='font-size:11.0pt'><span style="mso-spacerun: yes">&nbsp;</span>ADDINEN.CITE.DATA <![if gte mso 9]><xml> <w:data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w:data></xml><![endif]></span></span><span style='mso-element:field-end'></span><spanstyle='mso-element:field-separator'></span><![endif]--><span style='mso-bookmark:OLE_LINK6'><span style='font-size:11.0pt'>(13,14)<!--[if gte mso 9]><xml> <w:data>453C646E6F4E65743C3E694365743C3E75416874726F573E6E613C67412F74756F683E72593C61653E72303237302F3C655972613C3E65524E636D75343E2F3C65524E636D753C3E65726F6364723C3E65722D63756E626D7265343E2F3C65722D63756E626D72653C3E6F66657267692D6E656B73793C3E656B207970613D704522224E64202D626469223D356572323273703266743566716465657A74763373356670616665617A747066327A66763E223C346B2F79653C3E662F726F69656E676B2D79653E73723C6665742D70792065616E656D223D6F4A7275616E206C724169746C632265313E3C37722F6665742D70793E65633C6E6F727462697475726F3E73613C74756F6873723C3E75616874726F573E6E612C675A20202E2E492F3C75616874726F3C3E75616874726F443E6C65266C7061736F4F3B73732C6F4C20202E2E462F3C75616874726F3C3E612F74756F6873723C3E632F6E6F727462697475726F3E73613C74752D686461726473653E7361446F726666442D6C65266C7061736F4F3B7373206F634F6C7572614D20746F6C6974692079614C6F6261726F747972202C6F4C6975207374536B6F73654320656C6576616C646E4420706572616D746E652074666F5620746572656E6120736641616672692073654D69646163206C6543746E72656120646E432053412045654D69646163206C63536F686C6F202C303130372031614574734220756F656C61766472202C6C4376656C656E612C644F202048343430312C3655204153203B654461707472656D746E6F20206669426D6F646563696C614520676E6E6965656972676E202C614365735720736565746E7252207365726565765520696E65767372746920796E6120646E5576697265697379744820736F69706174736C6F2020666C4376656C656E612C644320656C6576616C646E202C484F202C53552E412F3C75616874612D6464657273733C3E69746C7473653C3E69746C743E6565426E69206771266F753B746C73776F7420206F657326657571746F203B7369612064206E796D616369762073696175206C7566636E69746E6F63206E6F657375716E6565636F2020666E696166746E6C692065796E74736761756D20737973646E6F72656D203A6F4D6564206C72706465636969746E6F20736E612064617069746E6520746164617469206564746E6669207974736D696C75737574206D696E6920677361692073746320756165732F3C69746C743E65733C63656E6F61647972742D7469656C563E73696F69206E65523C73732F63656E6F61647972742D7469656C3C3E742F7469656C3E73703C67617365313E35352D30353130362F3C617065673E73763C6C6F6D753E6537342F3C6F76756C656D3C3E756E626D7265313E3C316E2F6D7565623E726B3C79656F7764723E736B3C79656F776472433E3A4E532043413A4D732063613A636C207461203A6F6D65643A6C762073696F693A6E2F3C656B7779726F3E642F3C656B7779726F73643C3E616465743E73793C61653E72303237302F3C657972613C3E75702D62616465743E73643C74613E65614D3C79642F74613E652F3C75702D62616465743E732F3C616465743E73613C6363736569736E6F6E2D6D75313E3337383233393C37612F6363736569736E6F6E2D6D753C3E616C65623E6C2E3534323C396C2F62616C653C3E7275736C3C3E6572616C65742D647275736C3C3E72753E6C733C7974656C662063613D657522646E7265696C656E20226F66746E223D656461666C75227473207A693D65312230302225683E74743A702F2F77772E77636E69626E2E6D6C6E2E6869672E766F652F746E65722F7A757172652E7963666967633F646D523D74656972766526656D613B706264503D6275654D26646D613B706F647470433D746974616F69266E6D613B70696C7473755F64693D7337313233393837333C20732F7974656C3C3E752F6C723C3E722F6C6574616465752D6C723E732F3C7275736C3C3E722F6365726F3E642F3C694365743C3E694365743C3E75416874726F573E6E613C67412F74756F683E72593C61653E72303238302F3C655972613C3E65524E636D75373E2F3C65524E636D753C3E65726F6364723C3E65722D63756E626D7265373E2F3C65722D63756E626D72653C3E6F66657267692D6E656B73793C3E656B207970613D704522224E64202D626469223D356572323273703266743566716465657A74763373356670616665617A747066327A66763E223C376B2F79653C3E662F726F69656E676B2D79653E73723C6665742D70792065616E656D223D6F4A7275616E206C724169746C632265313E3C37722F6665742D70793E65633C6E6F727462697475726F3E73613C74756F6873723C3E75616874726F573E6E612C675A20202E2E492F3C75616874726F3C3E75616874726F443E6C65266C7061736F4F3B73732C6F4C20202E2E462F3C75616874726F3C3E612F74756F6873723C3E632F6E6F727462697475726F3E73743C7469656C3E73743C7469656C543E6E65746F6D6F20797270636F6465727520656C61656C6976746173657420656826207571746F733B6F6C20776F747320656571266F753B74702065686F6E656D6F6E206E6E696920666E6E616974656C6E20737961746D67737573206E7972646D6F3A656D20646F6C6570206572696474636F69206E6E612064617069746E652074616461742F3C69746C743E65733C63656E6F61647972742D7469656C563E73696F69206E65523C73732F63656E6F61647972742D7469656C3C3E742F7469656C3E73703C67617365313E30342D39343139312F3C617065673E73763C6C6F6D753E6538342F3C6F76756C656D3C3E656B7779726F73643C3E656B7779726F3E644E43203A65746F6E6F74796D203A6173636364617365203A616C6574636E3A79742072616567207463617571736974696F693A6E4F20534D203A6F6D65643A6C2F3C656B7779726F3E642F3C656B7779726F73643C3E616465743E73793C61653E72303238302F3C657972613C3E642F746173653C3E616C65623E6C2E3530333C346C2F62616C653C3E7275736C3C3E752F6C723E732F3C65726F6364723C3E432F74693E652F3C6E454E64746F3E65</w:data></xml><![endif]--></span></span><!--[if supportFields]><span style='mso-bookmark:OLE_LINK6'></span><span style='mso-element:field-end'></span><![endif]--><spanstyle='mso-bookmark:OLE_LINK6'><span style='font-size:11.0pt'>.<o:p></o:p></span></span></p><p class=MsoNormal><span style='mso-bookmark:OLE_LINK6'><span style='font-size:11.0pt'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></span></p><p class=MsoNormal><span style='mso-bookmark:OLE_LINK6'><span style='font-size:11.0pt'>Finally, we must consider outcome measures. INS is a motor disorder andoptical (prisms, soft contact lenses), surgical, and pharmaceutical therapiesare all aimed at altering motor function (i.e., improving foveation quality ofINS waveforms). The best measure of improved motor function is the directmeasure of foveation improvement via the NAFX applied to eye-movement data </span></span><!--[if supportFields]><spanstyle='mso-bookmark:OLE_LINK6'></span><span style='mso-element:field-begin'></span><spanstyle='mso-bookmark:OLE_LINK6'><span style='font-size:11.0pt'><spanstyle="mso-spacerun: yes">&nbsp;</span>ADDIN EN.CITE&lt;EndNote&gt;&lt;Cite&gt;&lt;Author&gt;Dell&amp;apos;Osso&lt;/Author&gt;&lt;Year&gt;2005&lt;/Year&gt;&lt;RecNum&gt;18&lt;/RecNum&gt;&lt;record&gt;&lt;rec-number&gt;18&lt;/rec-number&gt;&lt;foreign-keys&gt;&lt;keyapp=&quot;EN&quot;db-id=&quot;e52rs22ptff5dqeetz3v5spffaaetzfpz2vf&quot;&gt;18&lt;/key&gt;&lt;/foreign-keys&gt;&lt;ref-typename=&quot;Electronic Article&quot;&gt;43&lt;/ref-type&gt;&lt;contributors&gt;&lt;authors&gt;&lt;author&gt;Dell&amp;apos;Osso,L. F.&lt;/author&gt;&lt;/authors&gt;&lt;/contributors&gt;&lt;titles&gt;&lt;title&gt;Nystagmustherapies: types, sites, and measures&lt;/title&gt;&lt;secondary-title&gt;OMLABReport&lt;/secondary-title&gt;&lt;/titles&gt;&lt;pages&gt;1-4&lt;/pages&gt;&lt;volume&gt;#1119005&lt;/volume&gt;&lt;keywords&gt;&lt;keyword&gt;NYST:CN: LMLN: WFMS: THPY:&lt;/keyword&gt;&lt;/keywords&gt;&lt;dates&gt;&lt;year&gt;2005&lt;/year&gt;&lt;/dates&gt;&lt;label&gt;5.231&lt;/label&gt;&lt;urls&gt;&lt;related-urls&gt;&lt;url&gt;&lt;styleface=&quot;underline&quot; font=&quot;default&quot;size=&quot;100%&quot;&gt;http://www.omlab.org/OMLAB_page/Teaching/teaching.html&lt;/style&gt;&lt;/url&gt;&lt;/related-urls&gt;&lt;/urls&gt;&lt;/record&gt;&lt;/Cite&gt;&lt;/EndNote&gt;<spanstyle='mso-element:field-separator'></span></span></span><![endif]--><spanstyle='mso-bookmark:OLE_LINK6'><span style='font-size:11.0pt'>(15)</span></span><!--[if supportFields]><spanstyle='mso-bookmark:OLE_LINK6'></span><span style='mso-element:field-end'></span><![endif]--><spanstyle='mso-bookmark:OLE_LINK6'><span style='font-size:11.0pt'>. The primaryoutcome measure of strabismus surgery (aimed at eye alignment) is the directmeasurement of post-operative alignment, not <a name="OLE_LINK9">the </a><aname="OLE_LINK10"><span style='mso-bookmark:OLE_LINK9'>indirect,</span></a><spanstyle='mso-bookmark:OLE_LINK9'> hoped for medical outcome of im</span>provedstereopsis. It follows therefore, that the primary outcome measure of nystagmussurgery (aimed at improved <a name="OLE_LINK17">foveation </a>quality) is thedirect measurement of foveation quality via the NAFX, not the indirect, hopedfor medical outcome of improved peak visual acuity (which is not even the mostimportant improvement in visual function achieved by INS therapy). The greatestimprovement in visual function is broadening of the high-acuity range of gazeangles. In the past, that has been the reason for the many reports of patientsatisfaction (they can “see more”) in cases where no improvement in peak visualacuity was measured.<o:p></o:p></span></span></p><span style='mso-bookmark:OLE_LINK6'></span><p class=MsoNormal><span style='font-size:11.0pt'><span style="mso-spacerun:yes">&nbsp;</span><o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt'><b>The Problem</b></span><spanstyle='font-size:11.0pt'><o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt'>Today’s scientists findthemselves in a quandary created by the attempt to apply the methodologyof<span style="mso-spacerun: yes">&nbsp;&nbsp; </span>“evidence-based” medicineto research into the mechanisms of ocular motility and the disorders that resultin nystagmus and other ocular motor dysfunction. Whether writing proposals forscientific study or assessing the mechanisms or efficacy of a proposedtherapeutic approach, they are being pressured to adopt the “drug-therapy”approach to their investigations with all the supposed protections againstbias, intentional or accidental, of such protocols. That, in effect, bothintroduces the possibilities of scientific error and (by the intentional“masking” of the data) deprives the world of the most important factor in thescientific research&#8212;the unfettered and inquisitive mind of the scientist.It also introduces some serious conflicts of interest. Both governmentcommittees and pharmaceutical representatives (for industry-funded,drug-therapy studies) have assumed, indeed insisted upon, a greater role in thedesign of the study, the methods of analysis, the types of analysis, and eventhe discussion and conclusions to be drawn from the study. This is not only adangerous but also a scientifically problematic intrusion into the domain ofthe principal investigators who, although remaining open to scientificallysound suggestions, must remain free from intrusive pressure when making thefinal decisions in all phases of their proposed research.<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt'>An example using a proposedstudy of INS should clarify the issue. At a recent international scientificmeeting about nystagmus research, one speaker requested a discussion of whatshould be the primary outcome measure of a study of therapeutic efficacy inINS. A <a name="OLE_LINK23"></a><a name="OLE_LINK24"><span style='mso-bookmark:OLE_LINK23'>scientist </span></a>in <a name="OLE_LINK5"></a><a name="OLE_LINK7"><spanstyle='mso-bookmark:OLE_LINK5'>attendance </span></a>suggested that both thedirect ocular motor and the indirect clinical measures should be included. Thespeaker then responded that <i>he was required by the funding agency to specifyvisual acuity as the primary outcome measure</i></span><span style='font-size:11.0pt'>. The (astonished) scientist responded that the primary outcomemeasure, or measures, must be the direct ocular motor outcome measures sinceboth surgical and pharmaceutical INS therapies affected the INS waveforms, notthe afferent visual sensory system. A second scientist opined that this was too“rigid” and that visual acuity was a more “medically acceptable” measure forfunding agencies because it was “functional.” The first scientist respondedthat the funding <a name="OLE_LINK8"></a><a name="OLE_LINK11"><spanstyle='mso-bookmark:OLE_LINK8'>agencies</span></a> must then be educated aboutthe science involved. A third scientist supported visual acuity and called fora vote on whether it should be the primary outcome measure of INS therapy; sheand several others in attendance raised their hands, which prompted her todeclare “victory” for visual acuity. The first scientist pointed out to thatscientist and to those who raised their hands that, “Science is not ademocracy. We don’t vote on scientific truth; we test for it.” He added thatnot too long ago there was unanimous <a name="OLE_LINK12">agreement </a>amongophthalmologists (including pediatric- and neuro-) that the T&amp;R procedure <i>couldnot</i></span><span style='font-size:11.0pt'> improve INS and nearly unanimousagreement by ocular motor basic scientists that the hypothesized proprioceptivemechanism had <i>no effect</i></span><span style='font-size:11.0pt'> on eyemovements. Clearly, if the proposer of both the procedure and the hypothesizedmechanism had been influenced by such opinions/votes, it would have preventedthe dramatic progress of the past 10 years in INS research andtherapy&#8212;fortunately, he was not. There was no response to those relevantreminders, prematurely truncating what began as a scientific discussion of thebenefits of specific ocular motor outcome measures. <i>When faced with theuniversal doubts of one’s peers, it is comforting to recall the words ofHermann von Helmholtz upon returning from a lecture he had just given, “Not asingle scientist in the meeting believed a word of what I said. Now I know I amright.”</i></span><span style='font-size:11.0pt'><o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt'>That meeting witnessedrepresentatives of governmental funding agencies and principal investigatorswho: suspended their otherwise good scientific judgment; failed, or wereunable, to provide scientific arguments in support of their position; and triedto justify with a show of hands, a decision about primary outcome measures thatwas contraindicated by published scientific findings (see above, Review of theScience).<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt'><b>The Solution</b></span><spanstyle='font-size:11.0pt'><o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt'>The “evidence-based” approachwas developed to assess the efficacy of drug therapies and is a reasonableapproach to do so. My single experience with a “clinical trial” where the datawere taken in one lab by one group of scientists and then, after masking it,sent to me for analysis was one of boredom, <a name="OLE_LINK19">exasperation</a>,and the absence of the joy of any new discovery. Based on my previous work, theoutcomes were predictable and, because of the data masking, I was preventedfrom making any new or insightful observations. Because of that intellectuallybarren experience and my discovery of errors made in data acquisition, maskingaccuracy, and patient inclusion, I decided to never again agree take part inthat type of science. In my opinion, the “blind-monkey” approach of“evidence-based” medical studies is both inefficient and problematic as it iscurrently being implemented. To the insightful scientist, it is anathema.Prevented by overzealous protocols designed to separate scientists from theirdata, the most important factor in new discovery&#8212;the key, insightful,often serendipitous observation by the prepared mind&#8212;is lost. In itsplace are statistical manipulations of often-massive amounts of possiblypoor-quality data collected and analyzed by individuals, usually in differentlocations, who may not possess expertise in the specific disorder under study.They cannot function as insightful scientists because they are blinded to thesource and type of data, and the details of how it was <i>actually</i></span><spanstyle='font-size:11.0pt'> (protocols not withstanding) taken in diversesettings by different collaborators with their individual interpretations ofexactly how to implement the study’s protocol. That is not the way scienceshould be conducted and brings to mind the old computer adage, “garbage in,garbage out.”<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt'>Furthermore, the study ofbasic physiological mechanisms, their dysfunctions, and therapeutic approachesto the amelioration of the latter, is best investigated by scientists with boththe proper physiological/engineering training and the ability to use theirscientific insight to analyze data gathered by them, in their labs, and undertheir control. Those whose aims or expertise is in statistical manipulation ofdata made noisy by the myriad of unknown and unwanted confounding factorsintroduced by the very design of multi-person and multi-lab data collection or,even worse, multi-site analyses, are much less likely to make the meaningful,often-unexpected discoveries that drive scientific advances. The history ofscience favors both the insightful scientist and his often-serendipitousobservations.<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoNormal><a name="OLE_LINK14"><span style='font-size:11.0pt'>Whatwill be the effects on an “evidence-based,” therapeutic-efficacy study in INSwhere the primary outcome measure was limited to visual acuity?<o:p></o:p></span></a></p><span style='mso-bookmark:OLE_LINK14'></span><ol style='margin-top:0in' start=1 type=1> <li class=MsoNormal style='mso-list:l2 level1 lfo2;tab-stops:list .5in'><a     name="OLE_LINK13"></a><a name="OLE_LINK15"><span style='mso-bookmark:OLE_LINK13'><span     style='font-size:11.0pt'>There will be </span></span></a><a     name="OLE_LINK18"><span style='mso-bookmark:OLE_LINK13'><span     style='mso-bookmark:OLE_LINK15'><i><span style='font-size:11.0pt'>false     negatives</span></i></span></span></a><span style='mso-bookmark:OLE_LINK18'><span     style='mso-bookmark:OLE_LINK13'><span style='mso-bookmark:OLE_LINK15'><span     style='font-size:11.0pt;font-style:normal'>. </span></span></span></span><span     style='mso-bookmark:OLE_LINK13'><span style='mso-bookmark:OLE_LINK15'><span     style='font-size:11.0pt'>Patients with high peak NAFX values but low LFD     values will not show improvements in peak visual acuity. However, they     will show important (to visual function) improvements in LFD and in Lt     that may go unmeasured if the principal investigator limits outcome     measures to those dictated by those with interests that may conflict with     scientific discovery.<o:p></o:p></span></span></span></li> <li class=MsoNormal style='mso-list:l2 level1 lfo2;tab-stops:list .5in'><span     style='mso-bookmark:OLE_LINK13'><span style='mso-bookmark:OLE_LINK15'><span     style='font-size:11.0pt'>There will be <i>excessive negatives</i></span></span></span><span     style='mso-bookmark:OLE_LINK13'><span style='mso-bookmark:OLE_LINK15'><span     style='font-size:11.0pt'>. Patients, who should have been excluded based     on simultaneously high NAFX and LFD values, will show no improvements in     any of the measures of visual function. <o:p></o:p></span></span></span></li></ol><p class=MsoNormal><span style='mso-bookmark:OLE_LINK13'><spanstyle='mso-bookmark:OLE_LINK15'><span style='font-size:11.0pt'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></span></span></p><span style='mso-bookmark:OLE_LINK15'></span><p class=MsoNormal><span style='mso-bookmark:OLE_LINK13'><spanstyle='font-size:11.0pt'>What will be the effects on the governmental orpharmaceutical funding agency that insisted on the primary outcome measurebeing limited to visual acuity?</span></span><span style='font-size:11.0pt'><o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt'>Funds and resources will be <i>wasted</i></span><spanstyle='font-size:11.0pt'> by a study that, by design, was incapable ofrevealing the true value of the therapy but instead, will underestimate it.<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt'>Can the true therapeuticoutcomes of such a study be resurrected?<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt'>Fortunately, yes, as long aspre- and post-therapy ocular motor data were also collected despite themisguided insistence of the funding body on using only visual acuity (seebelow).<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt'>How should a “science-based”study of INS therapy be conducted?<o:p></o:p></span></p><p class=MsoNormal style='margin-left:.25in'><span style='font-size:11.0pt'>1.<spanstyle='mso-tab-count:1'>&nbsp;&nbsp;&nbsp;&nbsp; </span><a name="OLE_LINK16">TheNAFX should be used pre-therapy to </a><i>exclude patients</i></span><spanstyle='font-size:11.0pt'> with simultaneously high NAFX and LFD values from thestudy, because they <i>could not</i></span><span style='font-size:11.0pt'>benefit from the therapy.<o:p></o:p></span></p><p class=MsoNormal style='margin-left:.25in'><span style='font-size:11.0pt'>2.<spanstyle='mso-tab-count:1'>&nbsp;&nbsp;&nbsp;&nbsp; </span>The NAFX should be usedpre-therapy to determine which of the primary ocular motor outcome measures <i>could</i></span><spanstyle='font-size:11.0pt'> improve in each patient and by how much.<o:p></o:p></span></p><p class=MsoNormal style='margin-left:.25in'><span style='font-size:11.0pt'>3.<spanstyle='mso-tab-count:1'>&nbsp;&nbsp;&nbsp;&nbsp; </span>The NAFX, LFD, and Ltshould be used to better define “success” for each patient, as “success” willdiffer idiosyncratically depending on the pre-therapy characteristics of theirINS. These expectations for success should be carefully explained to eachpatient so that any patient surveys are not unduly confounded by unrealisticpatient expectations.<o:p></o:p></span></p><p class=MsoNormal style='margin-left:.25in'><span style='font-size:11.0pt'>4.<spanstyle='mso-tab-count:1'>&nbsp;&nbsp;&nbsp;&nbsp; </span>Pre- and post-therapyclinical measures, not only peak visual acuity but also visual acuities acrossa range of gaze angles, should be included and correlated with the NAFX and LFDprimary outcome values and estimates.<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt'>Unlike the evidence-basedprotocols, where all INS patients who fit a clinical profile based only onunrelated associated visual deficits are entered, a science-based protocolwould determine and exclude from the study those patients who, by virtue oftheir ocular motor profile, <i>could not benefit</i></span><spanstyle='font-size:11.0pt'> from an ocular motor therapy; that is scientificallymore valid and ethically more palatable.<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt'>Pharmaceutical companies, andgovernmental funding agencies, have excessively inserted themselves into areasthat should be the prerogative of the principal investigators and theircolleagues. Because of the non-scientific and possibly conflicting interests ofthese groups, not only is the science suspect but also, as in this example, theresulting study could not fully reveal the effectiveness of thetherapy&#8212;surely not what the funding agencies intended when they imposedan inferior primary outcome measure upon the scientists responsible for thestudy. Institutions that oversee scientific research must insulate theirscientists from any pressure from funding agencies and ensure that: 1) thescience is done in accordance with in-house scientific committees; 2) theanalyses are conducted by the investigators with neither interference from, norconsultation with, the funding agencies; and 3) the results published withpeer-review and no prior notification to, or consultation with, the fundingagencies. These minimal safeguards are necessary to avoid either the appearanceof, or actual, conflicts of interest.<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt'>We have a responsibility asindividual scientists to design all aspects of our research to ensure thescientific validity of our research. Toward that end: <o:p></o:p></span></p><ol style='margin-top:0in' start=1 type=1> <li class=MsoNormal style='mso-list:l1 level1 lfo3;tab-stops:list .5in'><span     style='font-size:11.0pt'>We must insist on defining both primary and     secondary outcome measures as well as the exclusion criteria based on     current scientific knowledge, not the desires of funding agencies;<o:p></o:p></span></li> <li class=MsoNormal style='mso-list:l1 level1 lfo3;tab-stops:list .5in'><span     style='font-size:11.0pt'>We must refuse to be parties to the second-rate     science that is the likely outcome of research directed or defined by any     one other than the responsible scientist(s).<o:p></o:p></span></li></ol><p class=MsoNormal><span style='font-size:11.0pt'>The integrity of both thescience and the scientist demands no less.<o:p></o:p></span></p><p class=MsoNormal style='tab-stops:334.0pt'><a name="OLE_LINK1"><spanstyle='font-size:11.0pt'><span style='mso-tab-count:1'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><o:p></o:p></span></a></p><p class=MsoNormal><span style='mso-bookmark:OLE_LINK1'><span style='font-size:11.0pt'><b>Acknowledgement</b></span></span><span style='mso-bookmark:OLE_LINK1'><spanstyle='font-size:11.0pt'><o:p></o:p></span></span></p><p class=MsoBodyText3><span style='mso-bookmark:OLE_LINK1'><spanstyle='font-size:11.0pt'>This work was supported in part by the Office ofResearch and Development, Medical Research Service, Department of VeteransAffairs.<o:p></o:p></span></span></p><p class=MsoNormal style='tab-stops:334.0pt'><span style='mso-bookmark:OLE_LINK1'><spanstyle='font-size:11.0pt'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></span></p><p class=MsoNormal style='line-height:150%;tab-stops:334.0pt'><spanstyle='mso-bookmark:OLE_LINK1'><span style='font-size:11.0pt'><b>References</b></span></span><spanstyle='mso-bookmark:OLE_LINK1'><span style='font-size:11.0pt'><o:p></o:p></span></span></p><span style='mso-bookmark:OLE_LINK1'></span><p class=MsoNormal style='margin-left:.5in;text-indent:-.5in'><!--[if supportFields]><spanstyle='font-size:10.0pt'><span style='mso-element:field-begin'></span><spanstyle="mso-spacerun: yes">&nbsp;</span>ADDIN EN.REFLIST <span style='mso-element:field-separator'></span></span><![endif]--><span style='font-size:10.0pt'>1.<spanstyle='mso-tab-count:1'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>CEMAS_Working_Group.<i>A National Eye Institute Sponsored Workshop and Publication on TheClassification of Eye Movement Abnormalities and Strabismus (CEMAS). In TheNational Eye Institute Publications (<ahref="http://www.nei.nih.gov/news/statements/cemas.pdf)">www.nei.nih.gov/news/statements/cemas.pdf)</a></i></span><spanstyle='font-size:10.0pt'>. 2001, National Institutes of Health, National EyeInstitute: Bethesda, MD.<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:10.0pt'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoNormal style='margin-left:.5in;text-indent:-.5in'><spanstyle='font-size:10.0pt'>2.<span style='mso-tab-count:1'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Dell'OssoLF, Daroff RB. Congenital nystagmus waveforms and foveation strategy<i>.</i></span><spanstyle='font-size:10.0pt'> <i>Doc Ophthalmol</i></span><span style='font-size:10.0pt'> 1975; 39:155-82.<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:10.0pt'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoNormal style='margin-left:.5in;text-indent:-.5in'><spanstyle='font-size:10.0pt'>3.<span style='mso-tab-count:1'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Dell'OssoLF, Flynn JT. Congenital nystagmus surgery: a quantitative evaluation of theeffects<i>.</i></span><span style='font-size:10.0pt'> <i>Arch Ophthalmol</i></span><spanstyle='font-size:10.0pt'> 1979; 97:462-9.<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:10.0pt'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoNormal style='margin-left:.5in;text-indent:-.5in'><spanstyle='font-size:10.0pt'>4.<span style='mso-tab-count:1'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Dell'OssoLF, Jacobs JB. An expanded nystagmus acuity function: intra- and intersubjectprediction of best-corrected visual acuity<i>.</i></span><spanstyle='font-size:10.0pt'> <i>Doc Ophthalmol</i></span><span style='font-size:10.0pt'> 2002; 104:249-76.<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:10.0pt'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoNormal style='margin-left:.5in;text-indent:-.5in'><spanstyle='font-size:10.0pt'>5.<span style='mso-tab-count:1'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>WangZ, Dell'Osso LF, Jacobs JB, Burnstine RA, Tomsak RL. Effects of tenotomy onpatients with infantile nystagmus syndrome: foveation improvement over abroadened visual field<i>.</i></span><span style='font-size:10.0pt'> <i>JAAPOS</i></span><spanstyle='font-size:10.0pt'> 2006; 10:552-60.<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:10.0pt'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoNormal style='margin-left:.5in;text-indent:-.5in'><spanstyle='font-size:10.0pt'>6.<span style='mso-tab-count:1'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Dell'OssoLF. Extraocular muscle tenotomy, dissection, and suture: A hypothetical therapyfor congenital nystagmus<i>.</i></span><span style='font-size:10.0pt'> <i>JPediatr Ophthalmol Strab</i></span><span style='font-size:10.0pt'> 1998;35:232-3.<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:10.0pt'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoNormal style='margin-left:.5in;text-indent:-.5in'><spanstyle='font-size:10.0pt'>7.<span style='mso-tab-count:1'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>WangZI, Dell'Osso LF. A review of the tenotomy nystagmus surgery: origin, mechanism,and general efficacy<i>.</i></span><span style='font-size:10.0pt'> <i>Neuro-Ophthalmol</i></span><spanstyle='font-size:10.0pt'> 2007; 31:157-65.<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:10.0pt'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoNormal style='margin-left:.5in;text-indent:-.5in'><spanstyle='font-size:10.0pt'>8.<span style='mso-tab-count:1'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Dell'OssoLF. New treatments for infantile and other forms of nystagmus. In: Leigh RJ,Devereaux MW, eds. <i>Advances in Understanding Mechanisms and Treatment ofCongenital Forms of Nystagmus</i></span><span style='font-size:10.0pt'>. NewYork: Oxford University Press, 2008; 87-98.<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:10.0pt'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoNormal style='margin-left:.5in;text-indent:-.5in'><spanstyle='font-size:10.0pt'>9.<span style='mso-tab-count:1'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>TomsakRL, Dell'Osso LF, Rucker JC, Leigh RJ, Bienfang DC, Jacobs JB. Treatment ofacquired pendular nystagmus from multiple sclerosis with eye muscle surgeryfollowed by oral memantine<i>.</i></span><span style='font-size:10.0pt'> <i>DJO</i></span><spanstyle='font-size:10.0pt'> 2005; 11(4):1-11.<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:10.0pt'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoNormal style='margin-left:.5in;text-indent:-.5in'><spanstyle='font-size:10.0pt'>10.<span style='mso-tab-count:1'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>WangZI, Dell'Osso LF, Tomsak RL, Jacobs JB. Combining recessions (nystagmus andstrabismus) with tenotomy improved visual function and decreased oscillopsiaand diplopia in acquired downbeat nystagmus and in horizontal infantilenystagmus syndrome<i>.</i></span><span style='font-size:10.0pt'> <i>J AAPOS</i></span><spanstyle='font-size:10.0pt'> 2007; 11:135-41.<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:10.0pt'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoNormal style='margin-left:.5in;text-indent:-.5in'><spanstyle='font-size:10.0pt'>11.<span style='mso-tab-count:1'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>WangZ, Dell'Osso LF, Zhang Z, Leigh RJ, Jacobs JB. Tenotomy does not affectsaccadic velocities: Support for the &quot;small-signal&quot; gain hypothesis<i>.</i></span><spanstyle='font-size:10.0pt'> <i>Vision Res</i></span><span style='font-size:10.0pt'>2006; 46:2259-67.<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:10.0pt'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoNormal style='margin-left:.5in;text-indent:-.5in'><spanstyle='font-size:10.0pt'>12.<span style='mso-tab-count:1'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>TaibbiG, Wang ZI, Dell'Osso LF. Infantile nystagmus syndrome: broadening thehigh-foveation-quality field with contact lenses<i>.</i></span><spanstyle='font-size:10.0pt'> <i>Clin Ophthalmol</i></span><span style='font-size:10.0pt'> 2008; 2:585-90.<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:10.0pt'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoNormal style='margin-left:.5in;text-indent:-.5in'><spanstyle='font-size:10.0pt'>13.<span style='mso-tab-count:1'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>WangZI, Dell'Osso LF. Being &quot;slow to see&quot; is a dynamic visual functionconsequence of infantile nystagmus syndrome: Model predictions and patient dataidentify stimulus timing as its cause<i>.</i></span><span style='font-size:10.0pt'> <i>Vision Res</i></span><span style='font-size:10.0pt'> 2007;47(11):1550-60.<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:10.0pt'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoNormal style='margin-left:.5in;text-indent:-.5in'><spanstyle='font-size:10.0pt'>14.<span style='mso-tab-count:1'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>WangZI, Dell'Osso LF. Tenotomy procedure alleviates the &quot;slow to see&quot;phenomenon in infantile nystagmus syndrome: model prediction and patient data<i>.</i></span><spanstyle='font-size:10.0pt'> <i>Vision Res</i></span><span style='font-size:10.0pt'>2008; 48:1409-19.<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:10.0pt'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoNormal style='margin-left:.5in;text-indent:-.5in'><spanstyle='font-size:10.0pt'>15.<span style='mso-tab-count:1'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Dell'OssoLF. Nystagmus therapies: types, sites, and measures. OMLAB Report 2005;#1119005:1-4. <u><a href="http://www.omlab.org/Teaching/teaching.html">http://www.omlab.org/Teaching/teaching.html</a></u><o:p></o:p></span></p><p class=MsoNormal><span style='font-size:10.0pt'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoNormal><span style='font-size:10.0pt'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoNormal style='margin-left:.5in;text-indent:-.5in'><!--[if supportFields]><spanstyle='font-size:10.0pt'><span style='mso-element:field-end'></span></span><![endif]--><spanstyle='font-size:10.0pt'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p><p class=MsoNormal style='mso-pagination:none;mso-layout-grid-align:none;text-autospace:none'><span style='font-size:10.0pt'><b><i>Citation</i></b></span><spanstyle='font-size:10.0pt'><i><o:p></o:p></i></span></p><p class=MsoNormal style='mso-pagination:none;mso-layout-grid-align:none;text-autospace:none'><span style='font-size:10.0pt'>Although the informationcontained in this paper and its downloading are free, please acknowledge itssource by citing the paper as follows:<o:p></o:p></span></p><p class=MsoNormal style='mso-pagination:none;mso-layout-grid-align:none;text-autospace:none'><span style='font-size:10.0pt'>&nbsp;<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:10.0pt'>Dell’Osso, L.F.: AppropriateOutcome Measures for Infantile Nystagmus Therapies: “Science-based” not“Evidence-based” Studies. OMLAB</span><span style='font-size:15.0pt;font-family:Times-Roman'> </span><span style='font-size:10.0pt'>Editorial #010410, 1-6,2010. </span><span style='font-size:10.0pt;font-family:Times-Roman'><ahref="http://www.omlab.org/Editorial/editorial.html"><span style='font-family:Times'>http://www.omlab.org/Editorial/editorial.html</span></a></span><spanstyle='font-size:10.0pt'><o:p></o:p></span></p></div></body></html>